Social Diabetes adjusts the hormone to the user crossing medical data with those obtained through the Internet of things.
The new technologies are being allied to control diabetes and customize their treatment.It is the safest path to deal with what many call the epidemic of the 21st century and whose fight is currently derived from 12% world health expenditure.The social diabetes company has a digital platform designed for control over the mobile of this disease and the self -management of medication, which resorts to the Internet of things and data analysis.
The application is based on a cloud database with nutritional information of 11,000 foods that you consult when the patient introduces the food it has taken.This information is combined with which the app receives from the person's glucometer with diabetes and the other devices to which in each specific case it is connected (it can be from the fitbit bracelets to the artificial intelligence engine of Amazon, Alexa, orto the Abott sensor, to name the main ones).The individual data history is also added.
All this ends up translating into an insulin recommendation adjusted to the patient's reality.The data, which are transferred to the application through Bluetooth or NFC, are integrated thanks to computer algorithms that are nourished from medical sources.Among the immediate plans of the company is to start using Machine Learning within one year, according to her CEO, María Salido.The application of the Catalan company currently has between 130,000 and 140,000 downloads worldwide, in more than 20 countries and in 11 languages.
Social Diabetes is one of the companies that has been highlighted this year with financing of the Program of the European Commission for Innovation Horizon 2020. The program values technical excellence and the product that is presented, the socio -economic impact of the initiative (poorly controlled diabetesIt can lead to serious health complications that represent a strong disbursement of public health) and the power of the candidate's business plan.
The result in the case of Social Diabetes is a financing of 1.6 million euros that the company must invest in the next two years.A boost and also a responsibility for this company that, despite its youth (born in 2012), counts its years for achievements.Salido defends his will to deepen his commitment to constant innovation, his need to also invest in clinical certifications and guarantees and his vocation to launch his business plan.
The application launched by Social Diabetes is growing.For two years the company collaborates with the public health systems of England and Scotland.He is also working with Sant Joan de Déu Hospital in Barcelona in the application of its platform for the control of children's and youth diabetes.
Another of the company's shortest -term projects is the creation of a specific social network for people with diabetes.The idea of this initiative is for patients to find in these forums value content.The participation of health professionals is also planned.The initiative will be completed within an approximate period of three or four months and already has the support of the Scottish public health system, which has been involved in it with a small subsidy and promoting a test in the country."The correct control of diabetes is fundamental because it derives in an expense to the health system that can be avoided," he says out.
